Drug Information

Drug General Information
Drug ID
D04BIH
Former ID
DNC013792
Drug Name
4-Phenylbutylcarbamic Acid Biphenyl-3-yl Ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529498]
Structure
Download
2D MOL

3D MOL
Formula
C23H23NO2
Canonical SMILES
C1=CC=C(C=C1)CCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
InChI
1S/C23H23NO2/c25-23(24-17-8-7-12-19-10-3-1-4-11-19)26-22-16-9-15-21(18-22)20-13-5-2-6-14-20/h1-6,9-11,13-16,18H,7-8,12,17H2,(H,24,25)
InChIKey
WZSGWNPOHRAUQO-UHFFFAOYSA-N
PubChem Compound ID
24881743
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529498]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.